- Home
- RERE vs CBLL Comparison
RERE vs CBLL Comparison
Compare RERE & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RERE | CBLL |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | China | United States |
| Employees | N/A | 280 |
| Industry | Other Specialty Stores | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 899.3M | 750.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | RERE | CBLL |
|---|---|---|
| Price | $3.91 | $17.84 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $23.20 |
| AVG Volume (30 Days) | ★ 1.2M | 240.0K |
| Earning Date | 05-19-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.27% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $25.70 | $29.57 |
| Revenue Next Year | $22.93 | $28.44 |
| P/E Ratio | $34.57 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.76 | $10.85 |
| 52 Week High | $6.47 | $24.33 |
Technical Indicators
Market Signals| Indicator | RERE | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 35.67 | 45.47 |
| Support Level | $3.69 | $17.11 |
| Resistance Level | $4.37 | $19.56 |
| Average True Range (ATR) | 0.18 | 0.82 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 9.60 | 35.89 |
Price Performance
Historical ComparisonAbout RERE ATRenew Inc.
ATRenew Inc is a pre-owned consumer electronics transactions and services platform in China. The majority of its revenue is derived from online product sales of phones and other consumer electronics goods through its platforms PJT Marketplace and Paipai Marketplace. The Company's principal operations and geographic markets are in the People's Republic of China.
About CBLL CeriBell Inc.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.